Literature DB >> 8535189

What is ineffective erythropoiesis in myelodysplastic syndromes?

D Bowen1.   

Abstract

The anaemia of MDS is multifactorial with intramedullary ineffective erythropoiesis resulting from an imbalance between erythroid proliferation, differentiation and apoptosis in favour of initial hypercellularity with high cell death through to a lower cellularity, lower death state with the eventual evolution of the leukaemic clone in many patients. The fundamental molecular abnormality(ies) in MDS, which produce the milieu for the heterogeneous molecular insults described (e.g., oncogene mutations) remains elusive. Many questions such as why MDS red cells are macrocytic and what are the precise cellular and molecular mechanisms of ineffective erythropoiesis remain unanswered but future study of the erythroid lineage should provide molecular clues to the earliest abnormalities in the pathogenesis of MDS.

Entities:  

Mesh:

Year:  1995        PMID: 8535189     DOI: 10.3109/10428199509059614

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  6 in total

1.  Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine β-thalassemia.

Authors:  Rajasekhar N V S Suragani; Sharon M Cawley; Robert Li; Samantha Wallner; Mark J Alexander; Aaron W Mulivor; Sara Gardenghi; Stefano Rivella; Asya V Grinberg; R Scott Pearsall; Ravindra Kumar
Journal:  Blood       Date:  2014-05-02       Impact factor: 22.113

Review 2.  Optimal management strategies for chronic iron overload.

Authors:  James C Barton
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Distinct roles for TET family proteins in regulating human erythropoiesis.

Authors:  Hongxia Yan; Yaomei Wang; Xiaoli Qu; Jie Li; John Hale; Yumin Huang; Chao An; Julien Papoin; Xinhua Guo; Lixiang Chen; Qiaozhen Kang; Wei Li; Vincent P Schulz; Patrick G Gallagher; Christopher D Hillyer; Narla Mohandas; Xiuli An
Journal:  Blood       Date:  2017-02-06       Impact factor: 22.113

4.  Hematopoietic cell fate and the initiation of leukemic properties in primitive primary human cells are influenced by Ras activity and farnesyltransferase inhibition.

Authors:  Craig Dorrell; Katsuto Takenaka; Mark D Minden; Robert G Hawley; John E Dick
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

5.  Clonality investigation of morphologically dysplastic hematopoietic cells in myelodysplastic syndrome marrows.

Authors:  Xiao Li; Lingyun Wu; Shaoxu Ying; Chunkang Chang; Quan Pu
Journal:  Int J Hematol       Date:  2008-02-07       Impact factor: 2.490

6.  Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis.

Authors:  Rajasekhar N V S Suragani; Samuel M Cadena; Sharon M Cawley; Dianne Sako; Dianne Mitchell; Robert Li; Monique V Davies; Mark J Alexander; Matthew Devine; Kenneth S Loveday; Kathryn W Underwood; Asya V Grinberg; John D Quisel; Rajesh Chopra; R Scott Pearsall; Jasbir Seehra; Ravindra Kumar
Journal:  Nat Med       Date:  2014-03-23       Impact factor: 53.440

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.